Literature DB >> 16076994

Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults.

Yung-Hsuan Shen1, Wei-Shiung Yang, Tzong-Hsi Lee, Long-Teng Lee, Ching-Yu Chen, Kuo-Chin Huang.   

Abstract

OBJECTIVES: The metabolic syndrome has become a significant health problem worldwide. In this study, we investigated the relationship between the metabolic syndrome, bright liver (BL) by ultrasonography (US), and plasma alanine aminotransferase (ALT) levels among apparently healthy adults. RESEARCH METHODS AND PROCEDURES: A total of 15,430 nonalcoholic healthy adults without hepatitis B or C were recruited from four nationwide MJ Health Screening Centers in Taiwan in 2000. Metabolic syndrome was defined using the National Cholesterol Education Panel (NCEP) metabolic syndrome criteria or modified NCEP criteria. Based on liver US, subjects were classified into either having BL or not. The relationship between the metabolic syndrome, BL, and ALT levels was examined using multivariate logistic regression analysis.
RESULTS: The crude OR of the metabolic syndrome was 13.92 (12.19 using modified NCEP criteria), and the age-BMI-sex-adjusted OR was 3.77 (3.71 using modified NCEP criteria) in subjects with BL vs. subjects without BL, respectively. The ORs of the metabolic syndrome were significantly higher in subjects with elevated ALT levels than in those with normal ALT levels. After adjustment for age, sex, and BMI, BL and elevated ALT level were independently associated with increased risk of the metabolic syndrome. DISCUSSION: Presence of BL and elevated plasma ALT level was independently associated with increased risk of the metabolic syndrome in adults. These factors contribute to a list of well-known risk factors, including obesity, aging, and male sex, and thus can be applied as an additional evaluation for the metabolic syndrome in a clinical setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076994     DOI: 10.1038/oby.2005.147

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  13 in total

1.  A review on laboratory liver function tests.

Authors:  Shivaraj Gowda; Prakash B Desai; Vinayak V Hull; Avinash A K Math; Sonal N Vernekar; Shruthi S Kulkarni
Journal:  Pan Afr Med J       Date:  2009-11-22

2.  Analysis of risk factors of metabolic syndrome using a structural equation model: a cohort study.

Authors:  Zhimin Ma; Ditian Li; Siyan Zhan; Feng Sun; Chaonan Xu; Yunfeng Wang; Xinghua Yang
Journal:  Endocrine       Date:  2018-08-21       Impact factor: 3.633

3.  The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.

Authors:  Chengyi Ding; Zhirong Yang; Shengfeng Wang; Feng Sun; Siyan Zhan
Journal:  Endocrine       Date:  2018-02-28       Impact factor: 3.633

4.  Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study.

Authors:  Ruben Hernaez; Hsin-Chieh Yeh; Mariana Lazo; Hui-Ming Chung; James P Hamilton; Ayman Koteish; James J Potter; Frederick L Brancati; Jeanne M Clark
Journal:  Hepatol Int       Date:  2013-10-17       Impact factor: 6.047

5.  Normal serum aminotransferase levels and the metabolic syndrome: Korean National Health and Nutrition Examination Surveys.

Authors:  Hyeon Chang Kim; Kui Son Choi; Young Hwa Jang; Hae Won Shin; Dae Jung Kim
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

6.  Gender difference on the development of metabolic syndrome: a population-based study in Taiwan.

Authors:  Lee-Ching Hwang; Chyi-Huey Bai; Chien-Jen Chen; Kuo-Liong Chien
Journal:  Eur J Epidemiol       Date:  2007-10-10       Impact factor: 8.082

7.  Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.

Authors:  Hsien-Liang Huang; Wen-Yuan Lin; Long-Teng Lee; Hsih-Hsi Wang; Wei-Jei Lee; Kuo-Chin Huang
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

8.  Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.

Authors:  D Enette Larson-Meyer; Bradley R Newcomer; Leonie K Heilbronn; Julia Volaufova; Steven R Smith; Anthony J Alfonso; Michael Lefevre; Jennifer C Rood; Donald A Williamson; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

9.  Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study.

Authors:  Kuo-Liong Chien; Hsiu-Ching Hsu; Chia-Lun Chao; Bai-Chin Lee; Ming-Fong Chen; Yuan-Teh Lee
Journal:  Cardiovasc Diabetol       Date:  2006-05-18       Impact factor: 9.951

10.  The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome.

Authors:  Zhixia Li; Xinghua Yang; Jun Yang; Zhirong Yang; Shengfeng Wang; Feng Sun; Siyan Zhan
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.